Heron Therapeutics
HRTX
#10086
Rank
HK$0.55 B
Marketcap
HK$2.91
Share price
26.48%
Change (1 day)
-66.33%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -HK$9.17

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.49. In 2022 the company made an earnings per share (EPS) of -HK$13.57 an increase over its 2021 EPS that were of -HK$17.64.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.17-32.38%
2022-HK$13.57-23.11%
2021-HK$17.64-10%
2020-HK$19.60-0%
2019-HK$19.601.21%
2018-HK$19.37-32.7%
2017-HK$28.78-19.34%
2016-HK$35.6854.76%
2015-HK$23.051.73%
2014-HK$22.66-16.23%
2013-HK$27.0591.67%
2012-HK$14.11-31.45%
2011-HK$20.59-27.06%
2010-HK$28.23-43.75%
2009-HK$50.19-57.33%
2008-HK$117.62-82.92%
2007-HK$688.5120.61%
2006-HK$570.87175.76%
2005-HK$207.02-21.43%
2004-HK$263.48100%
2003-HK$131.74-38.24%
2002-HK$213.29161.54%
2001-HK$81.55-106.46%
2000HK$1,2622051.55%
1999HK$58.64839.73%
1998HK$6.24-105.48%
1997-HK$113.95-88.16%
1996-HK$962.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-HK$9.65 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
HK$2.74-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$78.50-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$3.14-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-HK$23.21 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA